These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 6396835)
1. Plasmodium falciparum merozoite vaccine in Aotus monkeys. An evaluation of the tolerableness of three types of adjuvants. Peltola H; Case SE; Siddiqui WA; Perri SF Scand J Infect Dis; 1984; 16(4):393-402. PubMed ID: 6396835 [TBL] [Abstract][Full Text] [Related]
2. Reactogenicity of a malaria merozoite antigen in Aotus monkeys compared with the effects caused by two new adjuvants, CP-20,961 and [B30]-MDP. Peltola H; Case S; Perri SF; Siddiqui WA Scand J Infect Dis; 1983; 15(4):383-9. PubMed ID: 6361979 [TBL] [Abstract][Full Text] [Related]
3. Plasmodium falciparum merozoite vaccination in Aotus monkeys recovered spontaneously from P. falciparum infection: a clinical study. Peltola HO; Case SE; Perri SF; Siddiqui WA Scand J Infect Dis; 1982; 14(3):217-24. PubMed ID: 6755660 [TBL] [Abstract][Full Text] [Related]
4. Synthetic low-toxicity muramyl dipeptide and monophosphoryl lipid A replace Freund complete adjuvant in inducing growth-inhibitory antibodies to the Plasmodium falciparum major merozoite surface protein, gp195. Hui GS; Tam LQ; Chang SP; Case SE; Hashiro C; Siddiqui WA; Shiba T; Kusumoto S; Kotani S Infect Immun; 1991 May; 59(5):1585-91. PubMed ID: 2019429 [TBL] [Abstract][Full Text] [Related]
5. Immunization of experimental monkeys against Plasmodium falciparum: use of synthetic adjuvants. Siddiqui WA; Taylor DW; Kan SC; Kramer K; Richmond-Crum SM; Kotani S; Shiba T; Kasumoto S Bull World Health Organ; 1979; 57 Suppl 1(Suppl):199-203. PubMed ID: 120768 [TBL] [Abstract][Full Text] [Related]
6. Immunization of owl monkeys with the ring-infected erythrocyte surface antigen of Plasmodium falciparum. Collins WE; Anders RF; Ruebush TK; Kemp DJ; Woodrow GC; Campbell GH; Brown GV; Irving DO; Goss N; Filipski VK Am J Trop Med Hyg; 1991 Jan; 44(1):34-41. PubMed ID: 1996739 [TBL] [Abstract][Full Text] [Related]
7. Induction of protective immunity to monoclonal-antibody-defined Plasmodium falciparum antigens requires strong adjuvant in Aotus monkeys. Siddiqui WA; Tam LQ; Kan SC; Kramer KJ; Case SE; Palmer KL; Yamaga KM; Hui GS Infect Immun; 1986 Apr; 52(1):314-8. PubMed ID: 3514459 [TBL] [Abstract][Full Text] [Related]
8. Vaccination of experimental monkeys against Plasmodium falciparum: a possible safe adjuvant. Siddiqui WA; Taylor DW; Kan SC; Kramer K; Richmond-Crum SM; Kotani S; Shiba T; Kusumoto S Science; 1978 Sep; 201(4362):1237-9. PubMed ID: 99814 [TBL] [Abstract][Full Text] [Related]
9. A study of cellular and humoral immune responses in owl monkeys (Aotus trivirgatus) following vaccination against Plasmodium falciparum. Taylor DW; Siddiqui WA Bull World Health Organ; 1979; 57 Suppl 1(Suppl):247-53. PubMed ID: 120772 [TBL] [Abstract][Full Text] [Related]
10. Efficiency of human Plasmodium falciparum malaria vaccine candidates in Aotus lemurinus monkeys. Herrera S; Herrera MA; Certa U; Corredor A; Guerrero R Mem Inst Oswaldo Cruz; 1992; 87 Suppl 3():423-8. PubMed ID: 1343722 [TBL] [Abstract][Full Text] [Related]
11. Immunization trials with the ring-infected erythrocyte surface antigen of Plasmodium falciparum in owl monkeys (Aotus vociferans). Collins WE; Pappaioanou M; Anders RF; Campbell GH; Brown GV; Kemp DJ; Broderson JR; Coppel RL; Skinner JC; Procell PM Am J Trop Med Hyg; 1988 Mar; 38(2):268-82. PubMed ID: 3281493 [TBL] [Abstract][Full Text] [Related]
12. Immunogenicity of a chimeric Plasmodium falciparum merozoite surface protein vaccine in Aotus monkeys. Burns JM; Miura K; Sullivan J; Long CA; Barnwell JW Malar J; 2016 Mar; 15():159. PubMed ID: 26975721 [TBL] [Abstract][Full Text] [Related]
13. Use of a synthetic adjuvant in an effective vaccination of monkeys against malaria. Siddiqui WA; Kan SC; Kramer K; Case S; Palmer K; Niblack JF Nature; 1981 Jan; 289(5793):64-6. PubMed ID: 7005690 [No Abstract] [Full Text] [Related]
14. Merozoite vaccination of douroucouli monkeys against falciparum malaria. Mitchell GH; Richards WH; Butcher GA; Cohen S Lancet; 1977 Jun; 1(8026):1335-8. PubMed ID: 69057 [TBL] [Abstract][Full Text] [Related]
15. Preliminary observations on the efficacy of a recombinant multistage Plasmodium falciparum vaccine in Aotus nancymai monkeys. Collins WE; Galland GG; Barnwell JW; Udhayakumar V; Sullivan JS; Nace D; Tongren JE; Williams T; Roberts J; Shi YP; Lal AA Am J Trop Med Hyg; 2005 Oct; 73(4):686-93. PubMed ID: 16222010 [TBL] [Abstract][Full Text] [Related]
16. Immunogenicity and efficacy trials in Aotus nancymai monkeys with model compounds representing parts of a 75-kD merozoite surface antigen of Plasmodium falciparum. Sharma P; Ruebush TK; Campbell GH; Richman SJ; Wilkins PP; Broderson JR; Ardeshir F; Gross M; Silverman C; Skinner JC Am J Trop Med Hyg; 1992 Jun; 46(6):691-707. PubMed ID: 1621894 [TBL] [Abstract][Full Text] [Related]
17. Role of muramyl peptides for the enhancement of synthetic vaccines. Chedid L; Audibert F; Jolivet M Dev Biol Stand; 1986; 63():133-40. PubMed ID: 3527818 [TBL] [Abstract][Full Text] [Related]
18. Immunization of owl monkeys to Plasmodium falciparum with merozoites from cultures of a knobless clone. Trager W; Lanners HN; Stanley HA; Langreth SG Parasite Immunol; 1983 May; 5(3):225-36. PubMed ID: 6346229 [TBL] [Abstract][Full Text] [Related]
19. Immunogenicity and in vivo efficacy of recombinant Plasmodium falciparum merozoite surface protein-1 in Aotus monkeys. Kumar S; Yadava A; Keister DB; Tian JH; Ohl M; Perdue-Greenfield KA; Miller LH; Kaslow DC Mol Med; 1995 Mar; 1(3):325-32. PubMed ID: 8529111 [TBL] [Abstract][Full Text] [Related]
20. Adjuvant activity of 6-O-acyl-muramyldipeptides to enhance primary cellular and humoral immune responses in guinea pigs: dose-response and local reactions observed with selected compounds. Tsujimoto M; Kotani S; Shiba T; Kusumoto S Infect Immun; 1986 Sep; 53(3):517-21. PubMed ID: 3744549 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]